Announced Thu, 25 Jun · 11:46 IST
GSK Pharma receives Rs 3.54 cr demand notice from NPPA for overcharging
Regulatory & Legal View source PDF
GLAXO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-0.5%1-day move
₹2370.00
prior close
₹2381.30
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.1-0.1-0.1-0.2-0.5+3.4+2.5+1.6+1.6+1.6+3.6+7.8——
Up moveDown movePending
AI summary
GSK Pharma received a demand notice from the National Pharmaceutical Pricing Authority (NPPA) on 24 June 2026 for alleged overcharging on scheduled formulations. Total demand is Rs 3.54 crore, comprising Rs 1.23 crore in alleged overcharging and Rs 2.31 crore in interest. The company has stated there is no material impact on its financial operations and intends to file an appeal against the demand order.
Likely market impact
Company says no material financial impact and plans to appeal. Amount is small relative to GSK Pharma's overall size.